Literature DB >> 3354049

The global distribution of human immunodeficiency virus type 2 (HIV-2) infection.

C R Horsburgh1, S D Holmberg.   

Abstract

We reviewed published reports of infection with human immunodeficiency virus type 2 (HIV-2) to provide a picture of its geographic distribution, pathogenicity, modes of transmission, and risk to the blood supply. Since the first reports in 1986, 627 HIV-2-seropositive persons have been reported; 604 of these were in natives of West Africa. Acquired immunodeficiency syndrome (AIDS) had developed in 42 patients, while 8 patients had AIDS-related complex. Transmission by sexual intercourse was the usual reported mode of spread. The modes of transmission of HIV-2 are thought to be the same as those for HIV-1, but perinatal transmission and transmission by sharing of needles among intravenous drug abusers have not yet been reported. The virus has not been identified in blood donors in the United States or West Germany, but two HIV-2-infected blood donors were reported in France. Further epidemiologic studies are needed to define the spectrum of disease, modes of transmission, and risk of HIV-2 to the blood supply.

Entities:  

Mesh:

Year:  1988        PMID: 3354049     DOI: 10.1046/j.1537-2995.1988.28288179031.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  15 in total

1.  HIV-1 and HIV-2 in Spain.

Authors:  R Savall; X Balanzo; J L Fernandez; F Valls; V Soriano
Journal:  Genitourin Med       Date:  1992-04

2.  HIV-2 antibody testing of blood donors with doubtful immunoblot results for HIV-1.

Authors:  J Knüver-Hopf; H Mohr; J Beyer; B Lambrecht; D Mix; H Rübsamen-Waigmann; H Schmitt
Journal:  Blut       Date:  1989-03

3.  Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cells.

Authors:  H Kaneko; L P Neoh; N Takeda; H Akimoto; T Hishikawa; H Hashimoto; S Hirose; S Karaki; M Takiguchi; H Nakauchi; Y Kaneko; N Yamamoto; I Sekigawa
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  HTLV-I, HIV-1 and HIV-2 seroprevalences in Guadeloupe, French West Indies.

Authors:  G Agius; V Vaillant; G Dindinaud; M Bazillou; J F Zagury; V Kolesnitchenko; M Castets
Journal:  Eur J Epidemiol       Date:  1989-12       Impact factor: 8.082

5.  Human immunodeficiency virus type 2 in Spain.

Authors:  V Soriano; J Tor; A Ribera
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

6.  Human immunodeficiency virus type 2.

Authors:  G Hammond
Journal:  CMAJ       Date:  1989-01-15       Impact factor: 8.262

7.  Evaluation of Chiron HIV-1/HIV-2 recombinant immunoblot assay.

Authors:  R L Kline; D McNairn; M Holodniy; L Mole; D Margolis; W Blattner; T C Quinn
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

8.  First documented case of human immunodeficiency virus type 2 infection in an asymptomatic Swiss subject.

Authors:  P Bürgisser; L Odier; J Schüpbach; P C Frei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

9.  Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.

Authors:  P Kumar; H X Hui; J C Kappes; B S Haggarty; J A Hoxie; S K Arya; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

10.  Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal.

Authors:  C Donnelly; W Leisenring; P Kanki; T Awerbuch; S Sandberg
Journal:  Bull Math Biol       Date:  1993       Impact factor: 1.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.